Epidemiology of glioma: clinical characteristics, symptoms, and predictors of glioma patients grade I–IV in the the Danish Neuro-Oncology Registry

Ohgaki H, Kleihues P (2005) Epidemiology and etiology of gliomas. Acta Neuropathol 109(1):93–108

Ostrom QT, Bauchet L, Davis FG et al (2014) The epidemiology of glioma in adults: a “state of the science” review. Neuro-Oncology 16(7):896–913

Ohgaki H, Kleihues P (2005) Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 64(6):479–489

NORDCAN (2016) http://www-dep.iarc.fr/NORDCAN/English/frame.asp . Accessed 17 August 2016

The International Classification of Diseases—Oncology, version 3 (ICD-O-3) (2016) http://codes.iarc.fr/ . Accessed 17 August 2016

Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 14(2):97–109

Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131: 803–820

Salminen E, Nuutinen JM, Huhtala S (1996) Multivariate analysis of prognostic factors in 106 patients with malignant glioma. Eur J Cancer 32A(11):1918–1923

Stewart LA (2002) Glioma Metaanalysis Trialists (GMT) Group. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359:1011–1018

Ostrom QT, Gittleman H, Stetson L et al (2015) Epidemiology of gliomas. Cancer Treat Res 163:1–14

Hansen S, Nielsen J, Laursen RJ et al (2016) The Danish Neuro-Oncology Registry: establishment, completeness and validity. BMC Res Notes 9:425

Hansen S (2016) The Danish Neuro-Oncology Registry. Clin Epidemiol 8:629–632

Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655

Statistics Denmark (2016) http://www.statistikbanken.dk/ . Accessed 17 August 2016

Hill AB (1965) The environment and disease: association or causation? Proc R Soc Med 58:295–300

Posti JP, Bori M, Kauko T et al (2015) Presenting symptoms of glioma in adults. Acta Neurol Scand 131:88–93

Baldi I, Gruber A, Alioum A et al (2011) Descriptive epidemiology of CNS tumors in France: results from the Gironde Registry for the period 2000–2007. Neuro-Oncology 13(12):1370–1378

Ho VKY, Reijneveld JC, Roelien HE et al (2014) Changing incidence and improved survival of gliomas. Eur J Cancer 50:2309–2318

Christensen HC, Kosteljanetz M, Johansen C (2003) Incidence of gliomas and meningiomas in Denmark, 1943 to 1997. Neurosurgery 52:1327–1334

Deltour I, Auvinen A, Feychting M et al (2012) Mobile phone use and incidence of glioma in the Nordic countries 1979–2008: consistency check. Epidemiology 23(2):301–307

Deltour I, Johansen C, Auvinen A et al (2009) Time trends in brain tumor incidence rates in Denmark, Finland, Norway and Sweden, 1974–2003. J Natl Cancer Inst 101:1721–1724

Dahlrot RH, Kristensen BW, Hjelmborg J et al (2013) A population-based study of high-grade gliomas and mutated isocitrate dehydrogenase 1. Int J Clin Exp Pathol 6:31–40

Dahlrot RH, Kristensen BW, Hjelmborg J et al (2013) A population-based study of low-grade gliomas and mutated isocitrate dehydrogenase 1 (IDH1). J Neurooncol 114:309–317

Gittleman HR, Ostrom QT, Rouse CD et al (2015) Trends in Central Nervous System tumor incidence relative to other common cancer in adults, adolescents, and children in the United States, 2000 to 2010. Cancer 121:102–112

Hamilton W, Kernick D (2007) Clinical features of primary brain tumours: a case-control study using primary care records. Br J Gen Pract 57:695–699

Wöhrer A, Waldhör T, Heinzl M et al (2009) The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry. J Neurooncol 95:401–411

Probst HB, Hussain ZB, Andersen O (2012) Cancer patient pathways in Denmark as a joint effort between bureaucrats, health professionals and politicians—a national Danish project. Health Policy 105:65–70

Schmidt-Hansen M, Berendse S, Hamilton W (2015) Symptomatic diagnosis of cancer of the brain and central nervous system in primary care: a systematic review. Fam Pract 32(6):618–623

Lipton RB, Bigal ME, Diamond M et al (2007) Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 68:343–349

Rasmussen BK (1995) Epidemiology of headache. Cephalalgia 15:45–68

Laursen EL, Rasmussen BK (2012) A brain cancer pathway in clinical practice. Danish Med J 59(5):A4437

Valentinis L, Tuniz F, Valent et al (2010) Headache attributed to intracranial tumors: a prospective cohort study. Cephalalgia 30(4):389–398

Schankin CJ, Ferrari U, Reinish VM et al (2007) Characteristics of brain tumor-associated headache. Cephalalgia 27:904–911

Kahn K, Finkel A (2014) It IS a tumor—current review of headache and brain tumor. Curr Pain Headache Rep 18:421

Goffaux P (2010) Brain tumor headaches: from bedside to bench. Neurosurgery 67:459–466

Kirby S, Purdy A (2014) Headaches and brain tumors. Neurol Clin 32:423–432

De Luca GC, Bartleson JD (2010) When and how to investigate the patient with headache. Semin Neurol 30(2):131–144

Schwartzbaum J, Jonsson F, Ahlbom A et al (2005) Prior hospitalization for epilepsy, diabetes, and stroke and subsequent glioma and meningioma risk. Cancer Epidemiol Biomarkers Prev 14:643–650

Tucha O, Smely C, Preier M et al (2000) Cognitive deficits before treatment among patients with brain tumors. Neurosurgery 47:324–334